Ratings by Truist Securities (Danielle Brill)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/16/2026 | PTC Therapeutics | PTCT | New Coverage | Hold (N/A) |
60.99 (59.24) |
-2.87% | Details | |
| 10/16/2026 | Alkermes | ALKS | New Coverage | Buy (N/A) |
40.10 (41.22) |
2.79% | Details | |
| 10/8/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2026 | Rapport Therapeutics | RAPP | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2026 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2026 | Jefferson Capital | JCAP | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 8/12/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | Biogen | BIIB | Upgrade | Buy (Hold) |
199.15 (232.65) |
16.82% | Details | |
| 6/10/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 5/27/2026 | Vertex | VRTX | New Coverage | Buy (N/A) |
434.52 (499.74) |
15.01% | Details | |
| 5/22/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 5/18/2026 | Rapport Therapeutics | RAPP | New Coverage | Buy (N/A) |
37.07 (27.57) |
-25.63% | Details | |
| 5/13/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Hold (N/A) |
|
Details | ||
| 5/6/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/29/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | WAVE Life Sciences | WVE | New Coverage | Buy (N/A) |
6.94 (3.13) |
-54.9% | Details | |
| 4/27/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 4/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2026 | Centessa Pharmaceuticals | CNTA | Downgrade | Hold (Buy) |
39.76 (40.50) |
1.86% | Details | |
| 4/7/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Upstream Bio | UPB | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 3/25/2026 | Maze Therapeutics | MAZE | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2026 | Apogee Therapeutics Inc | APGE | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2026 | Apogee Therapeutics Inc | APGE | New Coverage | Hold (N/A) |
71.09 (135.07) |
90% | Details | |
| 3/17/2026 | Climb Bio | CLYM | New Coverage | Buy (N/A) |
7.13 (9.82) |
37.73% | Details | |
| 3/17/2026 | Maze Therapeutics | MAZE | New Coverage | Buy (N/A) |
51.26 (27.53) |
-46.29% | Details | |
| 3/9/2026 | Dianthus Therapeutics | DNTH | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | BridgeBio Pharma | BBIO | Maintain | (N/A) |
|
Details | ||
| 2/24/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Hold (N/A) |
|
Details | ||
| 2/20/2026 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Hold (Buy) |
34.39 (37.95) |
10.35% | Details | |
| 2/17/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Immunovant | IMVT | Maintain | Hold (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Hold (N/A) |
|
Details | ||
| 1/29/2026 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Insmed | INSM | New Coverage | Buy (N/A) |
198.46 (96.27) |
-51.49% | Details | |
| 12/15/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2025 | Jefferson Capital | JCAP | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Disc Medicine | IRON | Maintain | Buy (N/A) |
|
Details | ||
| 10/17/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Dianthus Therapeutics | DNTH | New Coverage | Buy (N/A) |
34.42 (72.09) |
109.44% | Details | |
| 10/14/2025 | Upstream Bio | UPB | New Coverage | Buy (N/A) |
20.08 (2.76) |
-86.25% | Details | |
| 10/14/2025 | Immunovant | IMVT | New Coverage | Hold (N/A) |
17.35 (26.73) |
54.06% | Details | |
| 10/2/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2025 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2025 | argenx SE | ARGX | New Coverage | Buy (N/A) |
756.39 (819.14) |
8.3% | Details | |
| 9/10/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2025 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2025 | Biogen | BIIB | New Coverage | Hold (N/A) |
124.99 (199.15) |
59.33% | Details | |
| 7/21/2025 | Tectonic Therapeutics Inc. | TECX | New Coverage | Buy (N/A) |
21.91 (20.65) |
-5.75% | Details | |
| 7/21/2025 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
15.69 (39.76) |
153.41% | Details | |
| 7/21/2025 | Disc Medicine | IRON | New Coverage | Buy (N/A) |
57.77 (56.84) |
-1.61% | Details | |
| 7/21/2025 | Jefferson Capital | JCAP | New Coverage | Buy (N/A) |
16.70 (20.53) |
22.93% | Details | |
| 7/21/2025 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
132.02 (135.71) |
2.8% | Details | |
| 7/21/2025 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
29.51 (120.30) |
307.66% | Details | |
| 7/21/2025 | Alnylam Pharmaceuticals | ALNY | New Coverage | Buy (N/A) |
320.53 (231.83) |
-27.67% | Details | |
| 7/21/2025 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
46.51 (66.39) |
42.74% | Details | |
| 7/21/2025 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
35.20 (37.95) |
7.81% | Details |
